Methotrexate (MTX) is an anti-metabolite in cancer chemotherapy and is associated with various toxicities assigned to inflammation and oxidative stress. The present study was undertaken to corroborate the therapeutic effects of bone marrow mesenchymal stem cells (BM-MSCs) and adipose-derived mesenchymal stem cells × 10 6 cells/rat, 1 week after last dose of MTX), respectively, plus V-Dex (0.5 mg/kg/ for 7 days, 1 week after last dose of MTX). MTX induced marked intestinal elevation of interleukin-6, total oxidant, and nitrite/ nitrate, caspase-3 contents and myeloperoxidase activity, along with the reduction of reduced glutathione content and catalase activity. In conclusion, the positive modulation of MTX toxicity could be attributed to the free radical scavenging, anti-inflammatory and antiapoptotic potential of BM-MSC and AD-MSCs which will possibly make them as remarkable hopeful for the treatment of intestinal injury
Introduction
Methotrexate (MTX) is an antagonist of folic acid [1] . MTX competitively inhibits the dihydrofolate reductase (DHFR) enzyme, which participates in the synthesis of folic acid and inhibits conversion of dihydrofolate to tetrahydrofolate. Subsequently, DHFR is essential for biosynthesis of thymidine and purines, which are needed for synthesis of DNA. Blockade of tetrahydrofolate synthesis by MTX leads to inability of cells to divide and to produce proteins [2] .
Subsequently, MTX is used as an antimetabolite in cancer chemotherapy in the treatment of lymphocytic leukemia, non-hodgkin's lymphoma, osteosarcoma, head neck cancer, and mammary gland tumors [3] . Moreover, MTX is also intervened for rheumatoid arthritis and refractory inflammatory disease treatments [4] .
Nevertheless, MTX is restrained by its toxicity, including intestinal injury causes severe mucositis [5] , enterocolitis, cardiotoxicity, nephrotoxicity and hepatotoxicity. Mucositis involves inflammation and mucosal ulceration of the alimentary tract, resulting in symptoms including pain, abdominal bloating, nausea, vomiting diarrhea and weight loss and disrupted chemotherapy [6, 7] . In addition, chemotherapy may exert cell damaging or a cell-destroying effect through the generation of reactive oxygen species, or through enzymatic or transcription factors (NF-ƘB) which leads to up regulation of genes responsible for production of proinflammatory cytokines TNF-α, IL-1β and IL-6. This leads to tissue injury and apoptosis [8] .
Bone-marrow mesenchymal stem cells to the secretion of several growth factors [9] . BM-MSCs reduce intestinal injury in rats [10] . Previous study demonstrated that MSCs can beneficially produce paracrine growth factors and anti-inflammatory cytokines [11] . It should be noted that MSCs respond to The present study aimed to study the therapeutic effects of BM-MSCs and AD-MSCs in MTX-induced intestinal injury in rats as compared with Dex. Standard pellet diet and water was allowed ad libitum.
Materials and methods

Animals
The investigation was complied with the Guide for Care Absorbance was read at 460 nm after 30 seconds for every 30 seconds for 2 minutes.
MPO was calculated in terms of (U/g) = where; ΔA= change of the sample absorbance over 2 minutes.
Besides, interleukien-6 (IL-6) was determined quantitatively by ELISA using a test reagent kit (SinoGeneClon Biotech Co., Ltd; China) according to the manufacturer's instructions. Intestinal IL-6 contents were estimated in the tested samples and determined as pg/g tissue from the standard curve constructed.
Determination of Intestinal Oxidative Stress Markers; Total Oxidant (TO), Reduced Glutathione (GSH), and Nitrite/Nitrate (NOx) Contents along with Catalase (CAT) Activity
The total oxidant (TO) content of samples was determined as previously described in [27] . In addition, determination of intestinal reduced glutathione (GSH)
was done according to the described method by Beutler et al. [28] and expressed as mg/g wet tissue. 
Statistical Analysis
The obtained results were presented as mean ± standard error of the mean. Comparisons between means were carried out using One-Way ANOVA followed by Tukey-Kramer multiple comparisons test. Statistical analysis was performed using GraphPad Prism software (version 5); a probability level of less than 0.05 was accepted as statistically significant. [49] .
Results
Identification of MSCs
In addition, the present study reported a prominent antioxidant as well as antiapoptotic effects for Dex. that probably exhibited elevated tissue GSH content and CAT activity in the settings of reduced MPO, TO, IL-6. Increasing of CAT activity may be by an enzymatic induction mechanism [50] , as well as the attempt of intestinal tissue to counteract the increase of free radical generation [51] . Dex administration declined mRNA expression of Caspase-3 as compared to MTX group. Dex was shown to suppress upregulation of pro-apoptotic factors, as well as and reduce caspase-3-like activity [52] .
Conclusion
We have demonstrated that treatment with MTX induced intestinal epithelial damage in wild type rats. 
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